Literature DB >> 2541906

Characterization of the antigen identified by Po66. A monoclonal antibody raised against a lung squamous cell carcinoma.

A Martin1, P Pellen, C Guitton, P Youinou, B Collet, B Desrues, D Bourel, L Dazord, L Toujas.   

Abstract

The mouse monoclonal antibody (mAb) Po66 has been shown in previous work to be localized in nude mice xenografts of human lung tumours when injected intravenously [Dazord L et al. (1987) Cancer Immunol Immunother 24: 263-268] and to be suitable for the scintigraphic detection of lung cancers in patients [Dazord L, et al. (1987) in Klapdor (ed) New tumour markers and their monoclonal antibodies. Georg Thieme, Stuttgart, New York, pp 444-450]. The nature of the antigen recognized by Po66 has been investigated in the present work and comparisons are made with antigens recognized by other mAbs prepared in the laboratory. These mAbs were raised either against lung squamous cell carcinoma (mAbs Po43, Po60), or against a bronchio-alveolar carcinoma (mAbs BAM33, BAM45, BAM54 and BAM69). Radioiodinated purified Po66 did not compete for cell binding with any other mAb. All Po and BAM mAbs reacted with tumour cells both cultured in vitro and grown in vivo. They recognized cytoplasmic antigens as judged by immunofluorescence examination of fixed cells or by immunoperoxidase staining of cancer tissues, but could never be visualized by immunofluorescence on the surface membrane of culture cells. The mAbs of the BAM series reacted with vimentin as demonstrated by immunofluorescence staining, showing alterations in the aspect of the filaments under the effect of colchicine. Radiolabelled mAbs Po43, BAM33 and BAM45 bound to partially purified cytoplasmic cytoskeleton components. In contrast, Po66 was never seen associated with intermediary filaments. The sensitivity to enzyme digestion of the antigen associated with Po66 was studied in comparison with those associated with Po43, BAM33 and BAM45. All antigens were sensitive to protease digestion while only the Po66-identified antigen was sensitive to periodate, neuraminidase and alpha-fucosidase. Thus, mAb Po66 identified an antigen of 47 kDa (as determined before) present in the cytoplasm but not related to the cytoskeleton, not detected on the cell surface and glycoprotein in nature.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2541906     DOI: 10.1007/bf00199286

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  19 in total

Review 1.  Differentiation of the major human tumor groups using conventional and monoclonal antibodies specific for individual intermediate filament proteins.

Authors:  M Osborn; M Altmannsberger; E Debus; K Weber
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

2.  Monoclonal antibodies against human oral squamous cell carcinoma reacting with keratin proteins.

Authors:  Y Myoken; T Moroyama; S Miyauchi; K Takada; M Namba
Journal:  Cancer       Date:  1987-12-15       Impact factor: 6.860

Review 3.  Substrate specificity of neuraminidases.

Authors:  R Drzeniek
Journal:  Histochem J       Date:  1973-05

4.  Comparison of the proteins of two immunologically distinct intermediate-sized filaments by amino acid sequence analysis: desmin and vimentin.

Authors:  N Geisler; K Weber
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

5.  Tumor localization in patients by radiolabeled monoclonal antibodies against colon carcinoma.

Authors:  J P Mach; J F Chatal; J D Lumbroso; F Buchegger; M Forni; J Ritschard; C Berche; J Y Douillard; S Carrel; M Herlyn
Journal:  Cancer Res       Date:  1983-11       Impact factor: 12.701

6.  Multicenter study of immunoscintigraphy with radiolabeled monoclonal antibodies in patients with melanoma.

Authors:  A G Siccardi; G L Buraggi; L Callegaro; G Mariani; P G Natali; A Abbati; M Bestagno; V Caputo; L Mansi; R Masi
Journal:  Cancer Res       Date:  1986-09       Impact factor: 12.701

7.  Monoclonal mouse antibodies raised against human lung carcinoma.

Authors:  I Hellström; D Horn; P Linsley; J P Brown; V Brankovan; K E Hellström
Journal:  Cancer Res       Date:  1986-08       Impact factor: 12.701

Review 8.  Heterogeneous expression of cell-surface antigens in normal epithelia and their tumours, revealed by monoclonal antibodies.

Authors:  P A Edwards
Journal:  Br J Cancer       Date:  1985-02       Impact factor: 7.640

Review 9.  Current ideas on the significance of protein glycosylation.

Authors:  C M West
Journal:  Mol Cell Biochem       Date:  1986 Nov-Dec       Impact factor: 3.396

10.  Monoclonal antibodies to intermediate filament proteins of human cells: unique and cross-reacting antibodies.

Authors:  A M Gown; A M Vogel
Journal:  J Cell Biol       Date:  1982-11       Impact factor: 10.539

View more
  2 in total

1.  Distribution of radiolabelled monoclonal antibody Po66 after intravenous injection into nude mice bearing human lung cancer grafts.

Authors:  B Desrues; B Collet; M P Ramé; D Bourel; P Bourguet; A Martin; P Delaval; L Toujas; L Dazord
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Monoclonal antibody Po66 uptake by human lung tumours implanted in nude mice: effect of co-administration with doxorubicin.

Authors:  B Desrues; H Léna; F Brichory; M P Ramée; L Toujas; P Delaval; L Dazord
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.